Literature DB >> 16740375

Annual fat mass change is a significant predictor of mortality in female hemodialysis patients.

Yoko Fujino1, Eiji Ishimura, Senji Okuno, Naoki Tsuboniwa, Kiyoshi Maekawa, Tsuyoshi Izumotani, Tomoyuki Yamakawa, Masaaki Inaba, Yoshiki Nishizawa.   

Abstract

BACKGROUND: Although obesity confers an increased risk of mortality in the general population, it has been reported to be associated with improved survival in dialysis patients. However, the influence of fat mass change over time on mortality in dialysis patients has not been determined.
METHODS: This relationship was examined in 190 female maintenance hemodialysis patients. Fat mass was measured twice with a 12-month interval, using dual energy X-ray absorptiometry (DEXA). The patients were followed up for 5 years, and predictors for all-cause death were examined using Kaplan-Meier analysis and Cox proportional hazards analyses.
RESULTS: During the 5-year follow-up period, 65 patients died. Annual fat mass changes in the expired group tended to be greater than in the surviving group (-1.0 +/- 2.5 vs. -0.3 +/- 2.6 kg; P = 0.0776), although initial body fat mass was not significantly different. Kaplan-Meier analysis revealed that patients with decreased fat mass (N = 110) had a significantly lower survival rate, compared with those with increased fat mass (N = 80; P = 0.021). Multivariate Cox proportional hazards analyses demonstrated that annual fat mass change was a significant predictor of all-cause mortality after adjustments for confounding factors, such as age, serum albumin, serum creatinine, and the presence of diabetes. An increase in annual fat mass of 1 kg reduced mortality by 14.5%.
CONCLUSIONS: These results demonstrate that the decrease in annual fat mass is a significant predictor for mortality in female hemodialysis patients. Fat mass change is also a useful parameter for measurement of nutritional status in hemodialysis patients.

Entities:  

Mesh:

Year:  2006        PMID: 16740375     DOI: 10.1016/j.biopha.2006.04.001

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

Review 1.  Accuracy and limitations of the diagnosis of malnutrition in dialysis patients.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2012-06-26       Impact factor: 3.455

2.  Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis.

Authors:  Agnieszka Turoń-Skrzypińska; Grażyna Dutkiewicz; Małgorzata Marchelek-Myśliwiec; Aleksandra Rył; Violetta Dziedziejko; Krzysztof Safranow; Kazimierz Ciechanowski; Iwona Rotter
Journal:  Risk Manag Healthc Policy       Date:  2020-09-07

Review 3.  Significance of Adipose Tissue Maintenance in Patients Undergoing Hemodialysis.

Authors:  Senji Okuno
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.